Pubblicazioni

A snapshot global survey on side effects of COVID-19 vaccines among healthcare professionals and armed forces with a focus on headache

2021 - PANMINERVA MEDICA

Perrotta, Armando; Biondi-Zoccai, Giuseppe; Saade, Wael; Miraldi, Fabio; Morelli, Andrea; Marullo, Antonino G; Cavarretta, Elena; Carnevale, Roberto; DE Falco, Elena; Chimenti, Isotta; Sciarretta, Sebastiano; Frati, Paola; Mamas, Mamas A; Ciardi, Sara; Frati, Luigi; Frati, Giacomo; Peruzzi, Mariangela

INfluenza Vaccine Indication during therapy with Immune checkpoint inhibitors: A multicenter prospective observational study (INVIDIa-2)

2021 - JOURNAL FOR IMMUNOTHERAPY OF CANCER

Bersanelli, M.; Giannarelli, D.; De Giorgi, U.; Pignata, S.; Di Maio, M.; Clemente, A.; Verzoni, E.; Giusti, R.; Di Napoli, M.; Aprile, G.; Ermacora, P.; Catino, A.; Scotti, V.; Mazzoni, F.; Guglielmini, P. F.; Veccia, A.; Maruzzo, M.; Rossi, E.; Grossi, F.; Casadei, C.; Ficorella, C.; Montesarchio, V.; Verderame, F.; Rizzo, M.; Guaitoli, G.; Fratino, L.; Accettura, C.; Mencoboni, M.; Zustovich, F.; Baldessari, C.; Cinieri, S.; Camerini, A.; Laera, L.; Soraru, M.; Zucali, P. A.; Guadalupi, V.; Leonardi, F.; Tiseo, M.; Tognetto, M.; Di Costanzo, F.; Pinto, C.; Negrini, G.; Russo, A.; Migliorino, M. R.; Filetti, M.; Buti, S.

Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients

2021 - ANNALS OF HEMATOLOGY

Scalzulli, E.; Caocci, G.; Efficace, F.; Rizzo, L.; Colafigli, G.; Di Prima, A.; Pepe, S.; Fegatelli, D. A.; Carmosino, I.; Diverio, D.; Latagliata, R.; La Nasa, G.; Martelli, M.; Foa, R.; Breccia, M.

Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy â A multicentre study of 90 patients from the German Dermatooncology Group

2021 - EUROPEAN JOURNAL OF CANCER

Grimmelmann, I.; Momma, M.; Zimmer, L.; Hassel, J. C.; Heinzerling, L.; Pfohler, C.; Loquai, C.; Ruini, C.; Utikal, J.; Thoms, K. -M.; Kahler, K. C.; Eigentler, T.; Herbst, R. A.; Meier, F.; Debus, D.; Berking, C.; Kochanek, C.; Ugurel, S.; Gutzmer, R.

Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT

2021 - BRITISH JOURNAL OF HAEMATOLOGY

Shimoni, A; Robin, M; Iacobelli, S; Beelen, D; Mufti, Gj; Ciceri, F; Bethge, W; Volin, L; Blaise, D; Ganser, A; Luft, T; Chevallier, P; Schwerdtfeger, R; Koster, L; de Witte, T; Kroger, N; Nagler, A; Yakoub-Agha, I

IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study

2021 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Lawless, S; Sbianchi, G; Morris, C; Iacobelli, S; Bosman, P; Blaise, D; Remenyi, P; Byrne, Jl; Mayer, J; Apperley, J; Lund, J; Kobbe, G; Schaap, N; Isaksson, C; Lenhoff, S; Basak, G; Touzeau, C; Wilson, Kmo; Muniz, Sg; Scheid, C; Browne, P; Anagnostopoulos, A; Rambaldi, A; Jantunen, E; Kroger, N; Schonland, S; Yakoub-Agha, I; Garderet, L